Literature DB >> 29262416

Consensus on Wound Antisepsis: Update 2018.

Axel Kramer1, Joachim Dissemond, Simon Kim, Christian Willy, Dieter Mayer, Roald Papke, Felix Tuchmann, Ojan Assadian.   

Abstract

Wound antisepsis has undergone a renaissance due to the introduction of highly effective wound-compatible antimicrobial agents and the spread of multidrug-resistant organisms (MDROs). However, a strict indication must be set for the application of these agents. An infected or critically colonized wound must be treated antiseptically. In addition, systemic antibiotic therapy is required in case the infection spreads. If applied preventively, the Wounds-at-Risk Score allows an assessment of the risk for infection and thus appropriateness of the indication. The content of this updated consensus recommendation still largely consists of discussing properties of octenidine dihydrochloride (OCT), polihexanide, and iodophores. The evaluations of hypochlorite, taurolidine, and silver ions have been updated. For critically colonized and infected chronic wounds as well as for burns, polihexanide is classified as the active agent of choice. The combination 0.1% OCT/phenoxyethanol (PE) solution is suitable for acute, contaminated, and traumatic wounds, including MRSA-colonized wounds due to its deep action. For chronic wounds, preparations with 0.05% OCT are preferable. For bite, stab/puncture, and gunshot wounds, polyvinylpyrrolidone (PVP)-iodine is the first choice, while polihexanide and hypochlorite are superior to PVP-iodine for the treatment of contaminated acute and chronic wounds. For the decolonization of wounds colonized or infected with MDROs, the combination of OCT/PE is preferred. For peritoneal rinsing or rinsing of other cavities with a lack of drainage potential as well as the risk of central nervous system exposure, hypochlorite is the superior active agent. Silver-sulfadiazine is classified as dispensable, while dyes, organic mercury compounds, and hydrogen peroxide alone are classified as obsolete. As promising prospects, acetic acid, the combination of negative pressure wound therapy with the instillation of antiseptics (NPWTi), and cold atmospheric plasma are also subjects of this assessment.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Acetic acid; Antiseptics; Drug; Dyes; Hydrogen peroxide; Hypochlorite; Iodophors; Medical device; Mercury compounds; Negative pressure wound therapy with the instillation of antiseptics; Octenidine; Physical body warm atmospheric plasma; Polihexanide; Silver ions; Silver sulfadiazine; Taurolidine; Wound antisepsis; Wounds-at-Risk Score

Mesh:

Substances:

Year:  2017        PMID: 29262416     DOI: 10.1159/000481545

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  35 in total

1.  Cold Atmospheric Plasma Disarms M1 Protein, an Important Streptococcal Virulence Factor.

Authors:  Sandra T Persson; Simon Ekström; Praveen Papareddy; Heiko Herwald
Journal:  J Innate Immun       Date:  2019-09-27       Impact factor: 7.349

Review 2.  [Incontinence-associated dermatitis: a position paper].

Authors:  J Kottner; N Kolbig; A Bültemann; J Dissemond
Journal:  Hautarzt       Date:  2020-01       Impact factor: 0.751

3.  Clinical Evaluation of the Efficacy and Tolerability of Rigenase® and Polyhexanide (Fitostimoline® Plus) vs. Hyaluronic Acid and Silver Sulfadiazine (Connettivina® Bio Plus) for the Treatment of Acute Skin Wounds: A Randomized Trial.

Authors:  Raffaele Russo; Albino Carrizzo; Alfonso Barbato; Barbara Rosa Rasile; Paola Pentangelo; Alessandra Ceccaroni; Caterina Marra; Carmine Alfano; Luigi Losco
Journal:  J Clin Med       Date:  2022-04-29       Impact factor: 4.964

4.  In vitro Activity of Antimicrobial Wound Dressings on P. aeruginosa Wound Biofilm.

Authors:  Ewa Klara Stuermer; Isabell Plattfaut; Michael Dietrich; Florian Brill; Andreas Kampe; Vanessa Wiencke; Anna Ulatowski; Maria Geffken; Julian-Dario Rembe; Ella Alexandrovna Naumova; Sebastian Eike Debus; Ralf Smeets
Journal:  Front Microbiol       Date:  2021-05-14       Impact factor: 5.640

5.  What COVID-19 taught us: New opportunities and pathways from telemedicine and novel antiseptics in wound healing.

Authors:  Alessandro Scalise; Marco Falcone; Giampiero Avruscio; Enrico Brocco; Eugenio Ciacco; Aurora Parodi; Rolando Tasinato; Elia Ricci
Journal:  Int Wound J       Date:  2021-10-02       Impact factor: 3.099

6.  Use of Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide for Chronic Wound Treatment.

Authors:  Alisha R Oropallo
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-01-15

7.  Potential of Biocellulose Carrier Impregnated with Essential Oils to Fight Against Biofilms Formed on Hydroxyapatite.

Authors:  Adam Junka; Anna Żywicka; Grzegorz Chodaczek; Mariusz Dziadas; Joanna Czajkowska; Anna Duda-Madej; Marzenna Bartoszewicz; Katarzyna Mikołajewicz; Grzegorz Krasowski; Patrycja Szymczyk; Karol Fijałkowski
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

8.  Susceptibility of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) to chlorhexidine digluconate, octenidine dihydrochloride, polyhexanide, PVP-iodine and triclosan in comparison to hospital-acquired MRSA (HA-MRSA) and community-aquired MRSA (CA-MRSA): a standardized comparison.

Authors:  Kathleen Dittmann; Thomas Schmidt; Gerald Müller; Christiane Cuny; Silva Holtfreter; Daniel Troitzsch; Peter Pfaff; Nils-Olaf Hübner
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-22       Impact factor: 4.887

Review 9.  Therapy of infected wounds: overcoming clinical challenges by advanced drug delivery systems.

Authors:  Pia Kaiser; Jana Wächter; Maike Windbergs
Journal:  Drug Deliv Transl Res       Date:  2021-02-20       Impact factor: 4.617

Review 10.  Antimicrobial stewardship of antiseptics that are pertinent to wounds: the need for a united approach.

Authors:  Jean-Yves Maillard; Günter Kampf; Rose Cooper
Journal:  JAC Antimicrob Resist       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.